))
Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma
Manage episode 371449566 series 3369804
Konten disediakan oleh Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
In this episode, we delve into the history of frontline treatment in young/fit patients with Hodgkin's lymphoma and recent developments in the past decade with Dr. Nancy Bartlett from Washington University.
Link for our Blood Cancer Talks Survey: https://bit.ly/BCTS
Here are the key trials we discussed:
1. RATHL Trial (PET-adapted treatment of Advanced Hodgkin’s Lymphoma):
https://pubmed.ncbi.nlm.nih.gov/27332902/
2. S0816 (PET-adapted treatment of Advanced Hodgkin’s Lymphoma):
https://pubmed.ncbi.nlm.nih.gov/27069074/
3. ECHELON-1 (Replacing Bleomycin by Brentuximab Vedotin in Advanced Hodgkin’s Lymphoma):
https://pubmed.ncbi.nlm.nih.gov/29224502/
https://pubmed.ncbi.nlm.nih.gov/35830649/
4. BREACH (BV-AVD vs ABVD for Early Stage Unfavorable Hodgkin’s Lymphoma):
https://pubmed.ncbi.nlm.nih.gov/35867960/
5. S1826 (Nivo-AVD vs BV-AVD in Advanced Hodgkin’s Lymphoma):
https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.17_suppl.LBA4
6. FIL-ROUGE (PET-adapted ABVD vs Dose-Intensified ABVD):
https://onlinelibrary.wiley.com/doi/10.1002/hon.3163_4
7. HD21 (BRECADD vs EBEACOPP in Advanced Hodgkin’s Lymphoma):
47 episode
Bagikan
